-
-
Toggle navigation
Impact Factor 4.137 | CiteScore 4.28
More on impact ›
in Oncology |
|
Submit your manuscript
Scope
This section is devoted to the publication of high-quality basic research in the molecular and cellular mechanisms contributing to cancer development and progression.
We aim to describe and highlight novel mechanistic insights into molecular pathways and cellular processes involved in oncogenesis, irrespective of the precise type of malignancy. The areas of interest include cell growth regulation, DNA damage and repair, signal transduction, metabolic reprogramming, cell death, sustained angiogenesis, tissue invasion and metastasis, avoidance of immunosurveillance, and tumor microenvironment. Submissions describing pathogenetic mechanisms of cellular transformation are of particular interest. In addition, transcriptomics, proteomics and metabolomics studies, which reveal new cellular or biochemical aspects of cancer biology are also welcomed.
Descriptive transcriptomics studies are not in scope for this Section.
Indexed in: PubMed, PubMed Central, Scopus, Google Scholar, DOAJ, CrossRef, Chemical Abstracts Service (CAS), Science Citation Index Expanded, CLOCKSS
Molecular and Cellular Oncology welcomes submissions of the following article types: Case Report, Clinical Trial, Correction, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Specialty Grand Challenge, Systematic Review and Technology and Code.
All manuscripts must be submitted directly to the section Molecular and Cellular Oncology, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Articles published in the section Molecular and Cellular Oncology will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in all Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Cell and Developmental Biology and Oncology.
Frontiers Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
Frontiers Support
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
support@frontiersin.org
There are no results to display.
Click on any of the keywords to find further editors related to it.
- Article(s) found
- Latest
- Most viewed
This section has no articles.
There are no articles to display. Please try changing the filters.
- Research Topic(s) found
- Latest
- Most viewed
Contact Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact oncology.editorial.office@frontiersin.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact oncology@frontiersin.org
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
For technical issues, please visit our Frontiers Help Center, or contact our IT HelpDesk team at support@frontiersin.org